Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.

MLA

Gutjahr, A., et al. “Bullous Pemphigoid Autoantibody-Mediated Complement Fixation Is Abolished by the Low-Molecular-Weight Heparin Tinzaparin Sodium.” The British Journal of Dermatology, vol. 181, no. 3, Sept. 2019, pp. 593–94. EBSCOhost, https://doi.org/10.1111/bjd.18156.

APA

Gutjahr, A., Heck, F., Emtenani, S., Hammers, A.-K., Hundt, J. E., Muck, P., Siegel, D. L., Schmidt, E., Stanley, J. R., Zillikens, D., & Hammers, C. M. (2019). Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium. The British Journal of Dermatology, 181(3), 593–594. https://doi.org/10.1111/bjd.18156

Chicago

Gutjahr, A, F Heck, S Emtenani, A-K Hammers, J E Hundt, P Muck, D L Siegel, et al. 2019. “Bullous Pemphigoid Autoantibody-Mediated Complement Fixation Is Abolished by the Low-Molecular-Weight Heparin Tinzaparin Sodium.” The British Journal of Dermatology 181 (3): 593–94. doi:10.1111/bjd.18156.